About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: June 26, 2014
    On January 7–8, 2014, the Institute of Medicine (IOM) held a workshop to explore examples of recent evaluation experiences that have drawn on an array of available methodologies applied in different ways to evaluate health and development initiatives. The workshop was an opportunity to reflect on the relative benefits and limitations of different evaluation design options that can be used within the context of a large-scale, complex initiative to reach credible conclusions and recommendations and to improve the implementation and performance of the evaluated initiative. This document summarizes the workshop.
  • Released: June 18, 2014
    On December 5, 2013, the IOM Roundtable on Population Health Improvement and the Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities co-sponsored a workshop to explore the history of social movements, both those that are health-related and those that are not primarily focused on health. The objective was to learn and discuss lessons that may be applied by those who are working to improve health and health equity in U.S. communities. This document summarizes the workshop.
  • Released: June 18, 2014
    On December 5, 2013, the IOM Roundtable on Population Health Improvement and the Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities co-sponsored a workshop to explore the history of social movements, both those that are health-related and those that are not primarily focused on health. The objective was to learn and discuss lessons that may be applied by those who are working to improve health and health equity in U.S. communities. This document summarizes the workshop.
  • Released: June 13, 2014
    Many of the elements of the Affordable Care Act (ACA) went into effect in 2014, and with the establishment of many new rules and regulations, there will continue to be significant changes to the U.S. health care system. It is unclear what impact these changes will have on medical and public health preparedness programs around the country. The implementation of the ACA provides an opportunity to consider how to better incorporate preparedness into all aspects of the evolving health care system and daily delivery of care. The IOM held a workshop to discuss how changes to the health system as a result of the ACA might impact medical and public health preparedness programs across the nation.
  • Released: June 12, 2014
    For the first time in decades, promising news has emerged regarding efforts to curb the obesity crisis in the United States. For example, obesity rates have fallen among low-income children in several states, the prevalence of obesity has plateaued among girls, and targeted efforts in some states have reduced the prevalence of obesity among children. Yet major problems remain. Diseases associated with obesity continue to incur substantial costs and cause widespread human suffering. In 2013 the IOM formed the Roundtable on Obesity Solutions to engage leadership from multiple sectors in addressing the obesity crisis. In January 2014, the roundtable held its first public workshop which featured presentations that described interventions designed to prevent and treat obesity in different settings.
  • Released: June 02, 2014
    At the April 2014 Preparedness Summit in Atlanta, Georgia, the Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events hosted a session to further the work on Crisis Standards of Care and the fair and ethical allocation of scarce resources during a medical or public health emergency.
  • Released: May 22, 2014
    Recent estimates suggest that, on average, it takes 10 years and at least $1 billion to bring a drug to market. Given this time and expense, pharmaceutical companies have become increasingly interested in finding new uses for existing drugs – a process referred to as drug repurposing or repositioning. In some cases where data have already been acquired, repurposing a drug can save time and money compared to developing a drug de novo. It has also been estimated that a larger percentage of repurposed drugs gain market approval as compared with drugs developed anew. In 2013, the IOM Roundtable on Genomic-Based Research for Health hosted a workshop to assess the current landscape of drug repurposing activities in industry, academia, and government.
  • Released: May 16, 2014
    Despite the critical importance of communication, many older adults have hearing loss that interferes with their social interactions and eAffiliateMarketIngtoolsment of life. People may miss words in a conversation, go to fewer public places, or worry about missing an alarm. Despite rapidly advancing technologies and innovative approaches to hearing health care, fewer than one in seven older Americans with hearing loss use hearing aids. In January 2014, the IOM and National Research Council held a workshop to examine the ways in which age-related hearing loss affects healthy aging, and how public and private stakeholders can work together to address hearing loss in older adults as a public health issue.
  • Released: May 15, 2014
    The low rate of translation of biomedical discoveries from basic science to clinical application has been a source of frustration for many scientists, clinicians, investors, policy makers, and patients who hoped that investments in research could result in improved products and processes for patients. Although understanding of human health and disease biology has increased, the anticipated deliverables from the Human Genome Project have not yet fully materialized and there has not been a consistent increase in approved drugs for patients over the past 10 years. The IOM Roundtable on Translating Genomic-Based Research for Health hosted a workshop to foster collaboration and the exchange of ideas among stakeholders to improve the utilization of genomic research for practical applications.
  • Released: May 02, 2014
    Many catastrophic disaster plans include provisions of support from neighboring jurisdictions that likely will not be available in a regional disaster.
https://pillsbank.net

comprar dapoxetine online

続きを読みます